Brief: Neurosense Receives Delisting Notice From Nasdaq And Intends To Appeal
Neurosense Therapeutics Ltd NRSN.O :
* NEUROSENSE RECEIVES DELISTING NOTICE FROM NASDAQ AND
INTENDS TO
APPEAL
Source text for Eikon: ID:nPn6cZT77a
Further company coverage: NRSN.O